secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2026-09-24T20:31:17+00:00
Accession:  0001801170-26-000229
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clover Health appoints former Sen. Robert Torricelli and Dr. Brian Miller to board
--------------------------------------------------------------------------------

- Senator Robert Torricelli appointed Class I director, Dr. Brian J. Miller Class III director, effective September 22, 2026.
- Torricelli joins Audit Committee; Miller joins Clinical Committee; board now nine directors, filling two vacancies.
- Each receives pro rata 2026 director retainer and $200,000 RSU prorated for service days through Dec 31, 2026.
- Torricelli is former U.S. Senator (NJ) and Clover insurance subsidiary board member since 2022; Miller is MedPAC commissioner and Johns Hopkins hospitalist.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117026000229/0001801170-26-000229-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117026000229/clov-20260922.htm
  HTML page:      https://secwatch.observer/filing/0001801170-26-000229

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer